A. Sochacki

发表

Remodeling of Retinal Fatty Acids in an Animal Model of Diabetes

G. Reid, T. Kern, T. Lydic, 2009, Diabetes.

N-3 Polyunsaturated Fatty Acids Prevent Diabetic Retinopathy by Inhibition of Retinal Vascular Damage and Enhanced Endothelial Progenitor Cell Reparative Function

G. Reid, S. Li Calzi, T. Lydic, 2013, PloS one.

The Unconventional Role of Acid Sphingomyelinase in Regulation of Retinal Microangiopathy in Diabetic Human and Animal Models

R. Kolesnick, T. Kern, T. Lydic, 2011, Diabetes.

Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes

Andrew L Sochacki, M. Savona, Melissa A. Fischer, 2016, OncoTargets and therapy.

A Phase 1, First-in-Human, Dose-Escalation Study of MGD024, a CD123 x CD3 Bispecific Dart® Molecule, in Patients with Relapsed or Refractory CD123-Positive (+) Hematologic Malignancies

M. Maris, E. Winer, P. Kaminker, 2022, Blood.

Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock

M. Boulton, N. Yakubova, S. L. Calzi, 2009, The Journal of experimental medicine.

Patient-specific comorbidities as prognostic variables for survival in myelofibrosis

T. Stricker, A. Bick, C. Bejan, 2022, Blood advances.

Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable.

H. Kantarjian, G. Garcia-Manero, J. Maciejewski, 2018, Blood.

Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock

M. Boulton, N. Yakubova, S. L. Calzi, 2009, Journal of Experimental Medicine.

Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock

M. Boulton, N. Yakubova, S. L. Calzi, 2009, The Journal of experimental medicine.

Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamics

C. Bejan, Hannah Poisner, C. Vlasschaert, 2023, medRxiv.

Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase Inhibition

G. Ayers, B. Skikne, Sheau-Chiann Chen, 2019, Blood.

Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamics.

C. Bejan, C. Vlasschaert, Travis P. Spaulding, 2024, The Journal of molecular diagnostics : JMD.

Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk

C. Bejan, C. Vlasschaert, A. Silver, 2024, Blood cancer journal.